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I N T R O D U C T I O N
Probably the first allusion to diabetes is 
contained in the papyrus Ebers, dated at about 
1500 B .C . and the symptomatology of the dis­
order was described by Aretaeus in the 1st 
century A .D . Prior to the late 17th  century 
the causation of diabetes was variously ascribed 
to excessive food, alcohol, sex or grief or to 
maladies of the stomach, arteries, blood, 
nervous and other systems. However, in 1683 
the Swiss Brunner recorded that pancreatec- 
tomised dogs displayed great thirst and 
polyuria before dying in coma, and in 1788 
Cawley reported destruction of the pancreatic 
tissue in a patient dying of diabetes. These 
observations were largely disregarded until fur­
ther evidence of a possible relationship between 
diabetes and the pancreas was provided by the 
classical experiments of von M ering and M in ­
kowski in 1890. T w enty years earlier Langer- 
hans, when aged 20, had described the islets to 
which his name was given in 1893 by Laguesse 
who was the first to suggest that they might 
produce an internal secretion. Schafer in 18 9 5 
considered that this secretion might profoundly 
modify the carbohydrate metabolism of the 
tissues and the name “ insuline”  was proposed 
by de M eyer in 1909. About 1900 O pie, in 
the U .S .A . and Ssobolew in Russia described 
hyaline changes in or destruction of the islets 
of Langerhans in diabetics and experimental
proof that diabetes was possibly due to defec­
tive function of islet cells was provided by 
M cC allum  in 1909. H e showed that ligation 
of the pancreatic duct, which caused atrophy 
of the exocrine pancreatic tissue, was not 
followed by diabetes but that subsequent 
destruction of the islet tissue resulted in the 
appearance of the disorder.
T h e first suggestion that diabetes in man 
m ight be an inherited disorder derives from 
the observations of M orton in 1696 who noted 
an extremely high prevalence of the disorder 
in certain families and this concept was 
established by von Naunyn in the early years 
of this century.
Banting and Best in 19 2 1 successfully 
extracted active insulin from the islet tissue of 
dogs’ pancreas and subsequently demonstrated 
that it reversed at least the major metabolic 
changes in experimentally diabetic dogs and in 
diabetic patients. Th is seemed in the 1920 ’s to 
have shown idiopathic diabetes to be due to 
a simple failure of the beta cells to secrete 
insulin either because of an inherited function­
al defect or structural changes in the pancreatic 
islets.
In the next two decades experimental work 
in animals demonstrated the influence of other 
hormones on diabetes. Thus Houssay and his 
colleagues showed that hypophysectom y amel­
iorated the diabetes of pancreatectomised
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animals, and Long and Lukens found adrenal­
ectomy to have a similar effect. In 1927 Johns 
et al demonstrated that injection of an extract 
of the anterior pituitary gland could cause 
hyperglycaemia and ten years later Young and 
his associates induced permanent diabetes in 
dogs by repeated injections of this material; in 
these diabetic animals beta cell changes occur­
red and in later years Young attributed this 
effect to growth hormone contained in the 
pituitary extract. However, the simplicity and 
consequent attractiveness of the hypothesis 
that idiopathic diabetes was due to inadequate 
insulin secretion was such that this view con­
tinued to be held until the mid 1950’s. By 
then, several techniques had been evolved to 
assay the insulin-like activity of plasma and 
pancreatic extracts. These led, in the next few 
years, to remarkable advances in the under­
standing of insulin metabolism, the factors in­
ducing its release from the pancreas, its effect 
on the liver, its enzymatic destruction, its 
distribution throughout the body and the 
forms in which it is present in the blood. 
Of particular importance, however, was the 
demonstration that the plasma of obese 
diabetics often contained excessive quantities 
of insulin or insulin-like activity. Furthermore 
in insulin-dependent diabetics accidentally 
killed early in the course of the disorder, the 
islets were not only hypertrophied but some­
times contained normal or increased amounts 
of extractable insulin. These observations 
suggested that the primary abnormality of 
idiopathic or essential diabetes lay outwith the 
pancreas and was not a simple failure of insulin 
secretion.
The early view, proposed by Mirsky, that 
unduly rapid destruction of insulin by insulin- 
ase (glutathione insulin transhydrogenase) 
accounted for the apparent reduction of the 
hormone’s activity in diabetes is no longer 
tenable; however, the concepts that diminished 
insulin activity might be due to its abnormal 
binding to protein in the plasma or the 
cell membrane or to the presence in the 
blood of anti-insulin factors or antagonists 
require further consideration. In addition 
there is the possibility that diabetes may be a 
gentically determined abnormality of messen­
ger R.N.A. leading to the production of 
insulins with altered molecular structure and 
activity. These possibilities are discussed 
below along with the glucose-fatty acid cycle
of Randle and more recent views concerning 
the genetics of the disorder. Ref. 1.
HEREDITY
Studies of the prevalence of overt diabetes 
and impairment of glucose tolerance in the 
relatives and families of diabetics have 
unequivocally revealed an inherited pre 
disposition to develop the disorder. Thus 
several investigations of twins, one of whom 
was diabetic, showed that the chances of the 
other twin having diabetes were about 85% if 
he was an identical twin and 30% if not 
identical.
However, the question of the mode or 
pattern of genetic transmission has only been 
seriously tackled since the early 1930’s. At 
that time Pincus and White found that the 
prevalence of diabetes among the offspring of 
two parents, neither or one or both of whom 
was diabetic, approximated to a ratio of 1 : 2 : 4 
respectively, which suggested that the disorder 
was inherited as a simple mendelian recessive 
with a penetrance of about 15-20% (i.e. that 
only 15-20% of those who were genetically 
liable to become clinically diabetic did so 
during their lifetime.)
Although this hypothesis was supported by 
the studies of Steinberg and Hanhart others 
have interpreted their own investigations to 
show either a dominant, a sex-linked, or in the 
case of juvenile-onset diabetics a recessive and 
in older-onset diabetics a dominant-type of in­
heritance. However, as pointed out by Clarke, 
it is rare for a common disease to be transmit­
ted by a single gene and by postulating incom­
plete penetrance it is possible to prove almost 
anything in genetics. In consequence it is not 
surprising that more recent studies suggest that 
diabetes is dependent on several genes (i.e. is 
multifactorial); this might include the domin­
ant transmission of the synalbumin-antagonist 
as discussed below. Thus, although idiopathic 
or essential diabetes is undoubtedly a genetic­
ally determined disorder much more inform­
ation is required to establish the mode of its 
transmission. (Refs. 2. 3. 4. 5.)
GROWTH HORMONE
The possibility that excessive secretion of 
growth hormone might be causally associated 
with the appearance of diabetes was based on 
the following observations: (1) a period of 
apparently very rapid growth sometimes pre­
ceded the appearance of the disorder in young 
persons, (2) pregnancy occasionally precipitated 
permanent or temporary diabetes, (3) the
r e p e a t e d  in jection  o f grow th  horm one —  albeit 
in exceedingly large doses —  caused diabetes 
in dogs and  (4) diabetes occurs in acrom egalic 
patients (although in on ly 20-30 %  of them ). 
The hypothesis was given fu rth er support by 
the reported find ing o f increased plasm a 
g r o w t h  horm one in d iabetics; how ever, the 
assay m ethod used was unsatisfactory and m ore 
r e c e n t  use o f the sensitive and accurate radio­
immunoassay has show n no evidence o f excess 
s e c r e t i o n  of grow th horm one e ith er under basal 
conditions or in response to secre togenic 
s t i m u l i  in diabetics or pre-diabetics. (R ef. 
6, 7).
ANOMALIES o f  t h e  g l u c o s e - f a t t y  a c i d  c y c l e
Randle and his colleagues h ave suggested 
that one o f the earliest, if not the prim ary, 
causes o f diabetes was a d efect o f the glucose- 
fatty acid  cycle  resulting in the increased 
release o f trig lycerides and free fa tty  acids 
which reduce both the uptake o f glucose by 
muscle and the effect o f insulin o n  the tissues. 
This suggestion was based firstly on the fact 
that fasting, w hich induces release o f these 
lipids, causes im paired glucose tolerance and 
relative insulin insensitivity  and secondly on 
observations m ade on norm al subjects and 
obese m ild  d iabetics fed  various types o f diets 
and subjected  to a glucose tolerance test. T h e  
possibility that the initial excess release o f the 
lipids m igh t be due to increased grow th hor­
mone activ ity  was also raised since this hor­
mone has these m etabolic  effects; m ore 
recently a lip o lytic  horm one derived from  the 
pituitary has been identified  and there is som e 
evidence that it m ay be increased in diabetes. 
However there are m any clin ical and experi­
mental observations w hich cannot be reconcil­
ed to this hypothesis. M oreover, am ong the 
earliest changes in m etabolism  that fo llow  upon 
inadequate insulin activ ity  is fat m obilisation 
with release o f triglycerides and fatty  acids; 
thus these latter changes arc likely  to be 
secondary rather than prim ary in relation to 
the cause of diabetes. (R e f. 8, 9).
I N S U L I N  A N T A G O N I S T S
Insulin antibodies, a lthough they m ay act as 
insulin antagonists, are found  only in patients 
taking exogenous insulin . H ow ever, from  
evidence obtained in a series o f studies dating 
from 19 5 5 , V a llan ce-O w en and his colleagues 
have carefu lly  developed a hypothesis that at 
least one o f the fund am ental causes o f diabetes 
is the presence in excess of a plasm a album in- 
bound insulin antagonist. T h e y  dem onstrated
that the album in  fraction  o f the p lasm a pro­
teins o f non-diabetics inh ib ited  the effect 011 
the rat d iaphragm  o f 1,000  m illi u n its/m l. 
insulin in vitro; this antagonism  was m arked 
w hen the a lbum in  was present in concen­
trations o f 3 .5 %  or m ore (i.e. w ith in  or above 
the physio logical range) but was lost in con ­
centrations of 1 .2 5 %  or less. H ow ever, the 
a lbum in  fraction o f plasm a o f patients having 
d iabetes, irrespective of its severity, and o f pre- 
or sub-clinical d iabe tics was strongly antagon­
istic at this low er concentration . B y  various 
techniques they w ere able to show  th at the 
a lbum in  itself had no in h ib ito ry  effect and that 
the antagonistic property was due to a p o ly ­
p eptide substance associated w ith  b u t separable 
from  the album in  —  this being term ed the 
“ synalbum in  antagonist” . A n  im po rtan t find­
ing was that the plasm a o f patients having 
“ secondary”  diabetes due to prim ary disease 
(e.g. h aem ochrom atosis) or rem oval o f the 
pancreas did not contain  excess synalbum in. 
F u rth er studies h ave show n this synalbum in- 
antagonist to have m any physico-chem ical 
sim ilarities to the B  chain o f insulin  and som e 
support to this suggestion has been provided 
by the dem onstration th at a lbum in  —  B  chain , 
prepared by incubating B  chain w ith  non- 
antagonistic album in , is m arked ly  antagonistic 
to insulin in vitro . H ow ever, insulin  antagon­
ism has n ot been dem onstrated  in vivo fo llow ­
ing the in jection  o f B  chain.
S in ce  it is not unusual fo r a b ioch em ical 
reaction to be inh ib ited  by a substance w hich 
ch em ically  resem bles that w hich  accelerates it, 
it  is n ot inconceivable that the B  chain , 
released by reductive cleavage o f the parent 
m olecu le under the in fluence o f insulinase, 
m igh t antagonise the effect o f endogenous 
insulin and thus bring ab o u t diabetes. H ow ­
ever, synalbum in  is present in the plasm a o f 
norm al persons so that if  this substance is the 
cause o f diabetes then the d isorder m ust result 
from  an exaggeration o f a norm al phenom enon. 
W h e th e r  or n ot carbohydrate intolerance or 
frank diabetes develops and the severity  of the 
diabetes should it occur, w ill depend on the 
am o u n t o f insulin antagonist present and the 
degree to w hich the beta cells can com pensate 
by p roducing m ore insulin . It  is o f consider­
ab le  interest that even in severe d iabetics, 
h y pop hysecto m y results in the d isappearance 
o f the synalbum in  antagonist w hich m ay 
explain  the considerable fall in insulin require­
m en t and , perhaps, the am eliorating  effect o f 
this procedure on certain types o f d iabetic
retinopathy. It  h as also been reported that 
synalbum in positivity occurs much more 
frequently in the relatives of diabetics than of 
non-diabetics; if synalbum in positivity is a valid 
biochem ical marker or indicator of the inherit­
ed diabetic diathesis then the disorder would 
seem to be transm itted as a m endelian dom in­
ant having a low degree of penetrance.
However, hypotheses related to the B chain 
album in-linked antagonist require further proof; 
and of some im portance is the fact that the 
antagonist does not inhibit the effect o f insulin 
o n  adipose tissue and there are no studies of 
its influence on insulin ’s activity on the liver 
which is certainly one of the m ost im portant 
organs contributing to the m etabolic defects 
in diabetes. (Refs. 6, 10 , 1 1 ) .
FR E E ,  BOUND AND A B N OR M AL  INSULINS
A lthough the subject is still somewhat 
confused it would appear that insulin is present 
in the blood in two main physical forms. T h e 
first is that in which it is liberated by the beta 
cells; this is called free or typical insulin. In 
vitro it is active on both m uscle and adipose 
tissue, and, because this activity is neutralised 
by insulin —  antiserum , it is also called sup- 
pressible insulin. In its second form insulin is 
bound to a protein, is active on fat but not 
m uscle and is not inhibited by antiserum ; this 
form is termed bound, atypical or non- 
suppressible insulin. Since only free insulin is 
detectable in the pancreatic vein whereas both 
occur peripherally, it is suggested that binding 
occurs in the liver. In  non-diabetics the ratio 
of free to bound insulin in the plasma varies 
according to the m etabolic state and needs of 
the body; for exam ple in fasting m ost of the 
insulin is present in bound form and after 
meals in free form. Several authorities, in 
particular Antoniades, have postulated that 
diabetes may be due to excessive insulin bind­
ing or an inability to convert bound into free 
insulin. Certainly the plasma of obese persons 
with mild diabetes contains an excessive 
proportion of bound insulin even after the 
adm inistration of glucose. Since the albumin- 
bound insulin antagonist, discussed above, does 
not inhibit insulin activity on fat this factor 
may be associated with the difference in m eta­
bolic activity between free and bound insulin. 
R ecent work by C ahill and his colleagues, 
however, suggests that in vivo only free insulin 
can pass into the extra-vascular fluids and thus 
be able to com e into contact with and influ­
ence the metabolism of peripheral tissue cells- 
thus an absolute reduction of free insulin' 
brought about by excessive binding of the’ 
remainder may be causally related to the 
m etabolic disturbance.
Insulinase, not only promotes the reductive 
cleavage of the disulphide bonds of insulin to 
release its A  and B  chains but can also bring 
about their reconjugation. T h e  possibility has 
been raised that a genetic defect of this 
enzym e’s activity m ight prom ote abnormal 
re-conjugation of the A and B chains resulting 
in new forms of insulin having e ither no 
activity or possessing antigenic properties. 
However, to date no consistent abnormality in 
the chem ical structure of insulin in human 
diabetes has been detected. (Refs. 12 , 13 ,
1 5.)
ROLE OF THE P AN CR E AS
T h e elucidation of the chem ical and mole­
cular structure of insulin by Sanger raised the 
possibility that diabetes m ight be due to the 
production of abnorm al insulins,'' the protein 
synthesis of insulin is under the influence of 
messenger R .N .A ., the form of which is 
genetically determ ined. However, there is as 
yet n o  evidence to support such a hypothesis,
Although the initial cause or causes of the 
m etabolic abnorm alities in diabetes is not a 
primary reduction in insulin secretion but 
rather a failure to produce enough extra 
insulin to overcome factors, of extra pancreatic 
origin, which diminish its effective activity, it 
m ust be remembered that secondary exhaustion 
of the beta cells can occur with decreasing 
capacity and eventual inability to produce 
insulin. T h is explains why diabetes controlled 
by diet alone may, after sonic years, require 
treatment with a sulphonylurea (which un­
couples insulin from inactive protein-bound 
com plexes), why secondary-sulphonylurea fail­
ure occurs and the efficacy of the diguanides 
(which potentiate the effect of insulin on the 
tissues) in such patients, and, of course, the 
developm ent of ketoacidosis when insulin 
therapy- is discontinued in insulin-dependent 
diabetics. Thus although the primary cause of 
diabetes lies outwith the pancreas, the meta­
bolic severity of the established disease depends 
very largely on the capacity of the beta cells 
to respond to the challenge; like a tired horse 
they may be flogged to death.
F inally it is necessary to consider obesity, 
pregnancy, stress and injury which are some­
times listed as causes of diabetes. T h ey are
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not causes of the disorder but may precipitate 
its overt clinical manifestations in those who
are genetically pre-disposed to diabetes. (Ref. 
16.)
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DIAGNOSTIC PROBLEM
Subject:
J .W ., M ale, Age 28; Rubber works employee. 
Presenting Com plaint:
Abdom inal colic and constipation.
History of Complaint :
Over the past six months J .W . has suffered 
from attacks of abdominal colic. These have 
been increasing in frequency and severity; they 
now occur about twice per week, and are not 
in any way related to time of day or to food 
of any type. T h e  pain is unrelieved by food, 
alkali or warmth. During an attack the pain 
is central abdominal of a colic type, and may 
last for up to two hours.
He has also complained of anorexia over the 
past two months; and generalised weakness, 







No history of any familial diseases.
Examination :
N o obvious jaundice or cyanosis. Marked 
pallor of mucous membranes and a pale com­
plexion.
C .V .S . —  Pulse 84. Regular in time and force. 
Apex beat in 5th interspace, within M .C .L . 
Heart sounds I and II. N o murmurs.
R .S . —  N o abnorm ality detected.
G .I.S . —  Tongue and fauces clean.
Dark line around gum margins.
Abdom en moves with respiration. No 
visible veins, peristalsis or masses.
N o guarding. No tenderness either direct 
or rebound.
N o masses palpable. Liver not enlarged. 
Spleen and kidneys not palpable.
C .N .S . —  N o loss of function detected in 
cranial nerves.
N o sensory peripheral loss.
Slight bilateral weakness of hand grip.
N o obvious muscle wasting.
Findings :
1 . History of abdominal colic, constipation, 
anorexia and weakness.
2 . Pallor of mucous membranes.
3. Darkening of g um margins.
4. W eakness of grip.
W h at is the diagnosis? H ow would you 
confirm it? How would you treat it?
Sec page 56.
